Is Your Drugstore Selling Your Private Information to Big Pharma?

For years, the big drugstore chains have stoutly denied selling prescription information—patient names, contact information, doctors’ names, and prescription details—to pharmaceutical companies for marketing use. Now, that charade has come to an end with two class action  suits, accusing CVS and Walgreen of doing just that.

In a civil suit in Philadelphia County Court, as Courthouse News reports, the city’s teachers union charged that consumers got unsolicited sales pitches after CVS allegedly sold customers’ private information to Eli Lilly and Co., Merck, AstraZeneca, Bayer, and other drug manufacturers. The union’s claim states:

 “Specifically, in exchange for the receipt of funds, direct promotional letters were sent to physicians of consumers by  defendant CVS Caremark in order to promote and tout specific prescription drugs of pharmaceutical manufacturers who contracted   with defendant CVS Caremark” for use of prescription information, according to the complaint.      

“While touted as an ‘RXReview Program’ by defendant CVS   Caremark, in reality, the physician communications were nothing more than a profit-making opportunity,” the class claims.

CVS’s scheme contradicts its “public pronouncements as to the sanctity of both consumers’ privacy and the physician-patient relationship,” according to the complaint.

Courthouse News goes on to report: “In 2009, CVS settled related claims from the Department of  Health and Human Services and Federal Trade Commission. Under the agreement with the health department, CVS paid $2.25 million to   settle claims related to  media reports that its pharmacies were throwing pill bottles with customers’ personal information into open dumpsters.”

A second law suit, in California, alleges that Walgreen unlawfully sold medical information gleaned from patient prescriptions, according to a Reuters report. In this case the plaintiffs accuse “Walgreen of depriving them of the commercial value of their own prescription information.’’

According to the suit, brought by Todd Murphy on behalf of his two daughters and the rest of the class of consumers, Walgreen sells the prescription information to data mining companies who resell it to pharmaceutical companies for marketing purposes. The practice allows drugmakers to target physicians considered high-volume prescribers and those most willing to prescribe new medications, it said.

So what’s the point of all this? If the facts in these suits prove to be correct, then when you take a prescription down to CVS or Walgreen, you are effectively releasing the information to just about everybody in the drug and related industries. It most certainly opens you to the possibility of a blizzard of pitches. And it opens the door for pitches to doctors to prescribe the same or possibly different new drugs. In addition, there’s no guarantee that this information won’t follow you around when you go to get a health insurance or life insurance policy. In short, your most personal health information–what medications you take, and for what conditions–is available to anyone who has the price of admission.


Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn't fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation today so we can keep on doing the type of journalism 2019 demands.

We Recommend


Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.


Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.


We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.